Analystreport

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) had its price target lowered by analysts at Royal Bank of Canada from $35.00 to $30.00. They now have an "outperform" r

Dicerna Pharmaceuticals, Inc.  (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com